Flucytosine

규격

2022-85-7CAS 번호

217-968-7EC 번호

6-amino-5-fluoro-1H-pyrimidin-2-oneIUPAC 명칭

C4H4FN3O화학식

129.09 g/mol분자량

5-Fluorocytosine; flucytosine; 2022-85-7; Fluorocytosine; Ancobon; Ancotil; Fluocytosine; 5-Fluorocystosine; Flucytosin; 5-Fluorocytosin; Fluorcytosine; Alcobon; Flucytosinum; 4-Amino-5-fluoropyrimidin-2(1H)-one; Ro 2-9915; Flucitosina; Cytosine, 5-fluoro-; 5-Flucytosine; 4-Amino-5-fluoro-2(1H)-pyrimidinone; 2(1H)-Pyrimidinone, 4-amino-5-fluoro-; 6-amino-5-fluoro-1H-pyrimidin-2-one; 2-Hydroxy-4-amino-5-fluoropyrimidine; DTXSID3023059; Flourocytosine; Ancoban; CHEBI:5100; Ro-2-9915; Ro-29915; NSC-103805; 6-amino-5-fluoro-1,2-dihydropyrimidin-2-one; NSC103805; D83282DT06; DTXCID403059; RefChem:58561; D01AE21; J02AX01; 217-968-7; 5-FC; 4-amino-5-fluoropyrimidin-2-ol; 117969-88-7; 5-fluoro cytosine; 5-Flurocytosine; Ro 29915 E/265601; 2-Pyrimidinol, 4-amino-5-fluoro- (9CI); 130256-61-0; Ancobon (TN); 2(1H)-Pyrimidinone, 6-amino-5-fluoro-; Flucytosine (Ancobon); 4-Amino-5-fluoro-2-hydroxypyrimidine; 6-amino-5-fluoropyrimidin-2(1H)-one; 2-Pyrimidinol, 4-amino-5-fluoro-; MFCD00006035; NSC 103805; 5-FLUORO-4-IMINO-1,2,3,4-TETRAHYDROPYRIMIDIN-2-ONE; MLS000069463; 4-AMINO-5-FLUORO-2(1H)-PYRIMIDINE; 2(1H)-Pyrimidinone, 5-fluoro-3,4-dihydro-4-imino- (9CI); 4-amino-5-fluoro-1,2-dihydropyrimidin-2-one; s1666; Flucytosine [USAN); 4-Amino-5-fluoro-1H-pyrimidin-2-one; NCGC00016599-01; Flucitosina [DCIT]; SMR000059047; ST028644; 6-amino-5-fluoro-3-hydropyrimidin-2-one; CAS-2022-85-7; FLUCYTOSINE [USAN]; Flucytosinum [INN-Latin]; Flucytosone; Ancotyl; pyrimidine, 4-amino-5-fluoro-2-hydroxy-; HSDB 3082; 6-Amino-2-oxo-5-fluoropyrimidine; EINECS 217-968-7; 6-Amino-5-fluoro-2(1H)-pyrimidinone; flucytosina; 2(1H)-Pyrimidinone, 4-amino-5-fluoro-); Flucytosine RS; Flucytosine CRS; 4-AMINO-2-HYDROXY-5-FLUOROPYRIMIDINE; 5-fluorocytocine; UNII-D83282DT06; 5-fluoro-cytosine; 4-Amino-5-fluoro-2-hyroxypyrimidine; GL663142 & 5FC; Flucytosine [USAN:USP:INN:BAN:JAN]; Flucytosine (Standard); CPD000059047; Opera_ID_178; 5-fluorocytosine Form I; FLUCYTOSINE [MI]; Prestwick0_000934; Prestwick1_000934; Prestwick2_000934; Prestwick3_000934; FLUCYTOSINE [INN]; FLUCYTOSINE [JAN]; 5-fluorocytosine Form II; F0321; FLUCYTOSINE [HSDB]; Epitope ID:613428; EC 217-968-7; 5-Fluorocytosine (5-FC); Flucytosine 100 microg/mL in Acetonitrile:Water; WLN: T6MVNJ DZ EF; CHEMBL1463; FLUCYTOSINE [MART.]; SCHEMBL24063; SCHEMBL24064; BSPBio_000868; FLUCYTOSINE [USP-RS]; FLUCYTOSINE [WHO-DD]; FLUCYTOSINE [WHO-IP]; MLS000759519; MLS001076503; MLS001424013; Flucytosine, 5-Fluorocytosine; SCHEMBL439755; SCHEMBL439756; SPBio_003037; BPBio1_000956; GL663142 & 4-Amino-5-fluoropyrimidin-2(1H)-one; orb1225747; orb1310101; orb3141367; SCHEMBL1223489; SCHEMBL4434518; Flucytosine (JP18/USP/INN); SCHEMBL14696800; HY-B0139R; FLUCYTOSINE [ORANGE BOOK]; 4-amino-5-fluoro-pyrimidin-2-ol; FLUCYTOSINE [EP MONOGRAPH]; FLUCYTOSINE [USP IMPURITY]; GLXC-21527; HMS1570L10; HMS2051M04; HMS2093J05; HMS2097L10; HMS2233I14; HMS3373L05; HMS3393M04; HMS3655G17; HMS3714L10; HMS5079P08; Pharmakon1600-01505429; 5-FLUOROCYTOSINE [WHO-IP]; FLUCYTOSINE [USP MONOGRAPH]; Flucytosine 2.0 mg/ml in Methanol; FLUCYTOSINUM [WHO-IP LATIN]; HY-B0139; Tox21_110515; BDBM50248003; EBC-04031; EBC-26058; MSK000319-100MW; NSC759130; SBB000061; STK292386; AKOS004912683; AKOS005063821; AKOS015896898; AKOS030241326; Flucytosine for system suitability CRS; Tox21_110515_1; CCG-100837; CCG-213434; CS-1935; DB01099; FF02813; GS-5578; KS-1060; NC00087; NSC-759130; SB57097; Cytosine, 5-fluoro- (6CI,7CI,8CI); NCGC00016599-02; NCGC00016599-04; NCGC00016599-05; NCGC00016599-09; AC-11748; BP-30254; EMTRICITABINE IMPURITY E [WHO-IP]; NCI60_000093; SY004438; DB-005380; DB-268955; DB-271174; AB00513969; F4581; NS00000532; SW197278-3; D00323; EN300-117264; H10295; AB00444223-16; AB00513969-02; AB00513969_03; AB00513969_04; 5-Fluorocytosine, Vetec(TM) reagent grade, 99%; F006215; Flucytosine Solution in Methanol/Water, 100ug/mL; Q238490; SR-01000721885; SR-01000721885-5; BRD-K82143716-001-15-7; BRD-K82143716-001-19-9; BRD-K82143716-001-20-7; 4-AMINO-5-FLUOROPYRIMIDIN-2(1H)-ONE [WHO-IP]; Z1201621875; Flucytosine, European Pharmacopoeia (EP) Reference Standard; 2(1H)-PYRIMIDINONE, 5-FLUORO-3,4-DIHYDRO-4-IMINO-; Flucytosine, United States Pharmacopeia (USP) Reference Standard; Flucytosine, Pharmaceutical Secondary Standard; Certified Reference Material; Flucytosine for system suitability, European Pharmacopoeia (EP) Reference Standard; 1LD동의어